Prevention and Correction of Hypoglycemia: Relevance to Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Hypoglycemia is the limiting factor in the glycemic management of diabetes because it generally precludes maintenance of euglycemia. Improving glycemic control while minimizing hypoglycemia in type 1 diabetes mellitus (T1DM) and advanced type 2 diabetes (T2DM) involves both application of the principles of aggressive therapy—patient education and empowerment, frequent self-monitoring of blood glucose, flexible insulin regimens, individualized glycemic goals, and ongoing professional guidance and support—and implementation of hypoglycemia risk reduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reichard, P., Nilsson, B.-Y., & Rosenqvist, U. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290502 · Cited by 1,202
Effect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Turner, R., Stratton, I., Horton, V., Manley, S., Zimmet, P., Mackay, I. R., Shattock, M., Bottazzo, G. F., & Holman, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03062-6 · Cited by 779
RIZZA, R. A., MANDARINO, L. J., & GERICH, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-131 · Cited by 696
Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1973) · Science · doi:10.1126/science.182.4108.171 · Cited by 688
Clutter, W. E., Bier, D. M., Shah, S. D., & Cryer, P. E. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109840 · Cited by 576
Self-citationMitrakou, A., Ryan, C., Veneman, T., Mokan, M., Jenssen, T., Kiss, I., Durrant, J., Cryer, P., & Gerich, J. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.1.e67 · Cited by 558
Self-citationEpinephrine-induced insulin resistance in man
Deibert, D. C., & Defronzo, R. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109718 · Cited by 557
Research works printed but not linked: 41
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977–986. · DOI · Paper page
- The United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352: 837–853. · DOI · Paper page
- Cryer PE. Hypoglycemia. Pathophysiology, Diagnosis and Treatment. Oxford University Press, New York, 1997. · DOI · Paper page
- Cryer PE. Hypoglycemia is the limiting factor in the management of diabetes. Diabetes/Metab Res Rev 1999;15: 42–46. · DOI · Paper page
- The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997;46: 271–286 · DOI · Paper page
- Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus: The Stockholm Diabetes Intervention Study after 5 years. J Intern Med 1990;230: 101–108. · DOI · Paper page
- The United Kingdom Prospective Diabetes Study Group. A 6-year, randomized, controlled trial cornparing sulfonylurea, insulin and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med 1998;128: 165–175. · DOI · Paper page
- Egger M, Davey Smith G, Stettler C, Diem P. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: A meta-analysis. Diabet Med 1997;14: 919–928. · DOI · Paper page
- Laing SP, Swerdlow AJ, Slater SD, Bothat JL, Burden AC, Waugh NR, et al. The British Diabetic Association Cohort Study. II. Cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 1999;16: 466–471. · DOI · Paper page
- Hepburn DA, MacLeod KM, Pell ACH, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med 1993;10: 231–237. · DOI · Paper page
- Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich J. Renal glucose production and utilization: new asnects in humans. Diabetologia 1997;40: 749–757. · DOI · Paper page
- Schwartz NS, Clutter WE, Shah SD, Cryer PE. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest 1987;79: 777–781. · DOI · Paper page
- Boyle PJ, Cryer PE. Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, prolonged hypoglycemia in humans. Am J Physiol 1991;260: E395–E402.
- Amiel SA, Simonson DC, Sherwin RS, Lauritano AA, Tamborlane WV. Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children. J Pediatr 1987;110: 832–837. · DOI · Paper page
- Jones TW, Borg WP, Boulware SD, McCarthy G, Sherwin RS, Tamborlane WV. Enhanced adrenomedullary response and increased susceptibility to neuroglycopenia: mechanisms underlying the adverse effects of sugar ingestion in healthy children. J Pediatr 1995;126: 171–177. · DOI
- Fanelli C, Pampanelli S. Epifano L, Rambotti AM, Ciofetta M, Modarelli F, et al. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 1994;37: 797–807. · DOI · Paper page
- Mitrakou A, Fanelli C, Veneman T, Perriello G, Platanisoto D, Rambotti A, et al. Reversibility of hypoglycemia unawareness in patients with an insulinoma. N Engl J Med 1993;329: 834–839. · DOI · Paper page
- Boden G, Reichard GA Jr, Hoeldtke RD, Rezvani I, Owen OE. Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. N Engl J Med 1981;305: 1200–1205. · DOI · Paper page
- Hirsch BR, Shamoon H. Defective epinephrine and growth hormone responses in type 1 diabetes are stimulus specific. Diabetes 1987;36: 20–26. · DOI
- Widom B, Simonson DC. Intermittent hypoglycemia impairs glucose counterregulation. Diabetes 1992;41: 1597–1602. · DOI
- Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 1993;42: 1233–1237. · DOI
- Lingenfelser T, Renn W, Sommerwerck U, Jung ME, Buettner UW, Zaiser-Kaschel H, et al. Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypoglycemia in IDDM patients. Diabetes 1993;42: 610–618. · DOI
- Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994;17: 697–703. · DOI · Paper page
- Cryer PE. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious cycle. Diabetes 1992;41: 255–260. · DOI
- Fanelli CG, Paramore DS, Hershey T, Terkamp C, Ovalle F, Craft S, et al. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes mellitus. Diabetes 1998;47: 1920–1927. · DOI · Paper page
- Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994;43: 1426–1434. · DOI
- Cranston I, Lomas J, Maran A, Macdonald I, Amiel S. Restoration of hypoglycemia unawareness in patients with long duration insulin-dependent diabetes mellitus. Lancet 1994;344: 283–287. · DOI · Paper page
- Davis SN, Shavers C, Davis B, Costa F. Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. J Clin Invest 1997;100: 429–438. · DOI · Paper page
- Boyle PJ, Kempers SF, O’Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin dependent diabetes mellitus. N Engl J Med 1995;333: 1726–1731. · DOI · Paper page
- Segel S, Fanelli C, Dence C, Markham J, Videen T, Paramore D, et al. Blood-to-brain glucose transport is not increased following hypoglycemia. Diabetes 2001;50: 1911–1917. · DOI · Paper page
- Berlin I, Grimaldi A, Payan C, Sachon C, Bosquet F, Thervet F, et al. Hypoglycemic symptoms and decreased β-adrenergic sensitivity in insulin dependent diabetic patients. Diabetes Care 1987;10: 742–747. · DOI · Paper page
- Korytkowski M, Mokan M, Veneman T, Mitrakou A, Cryer P, Gerich JE. Reduced β-adrenergic sensitivity in insulin dependent diabetic patients. Diabetes Care 1998;21: 1939–1943. · DOI · Paper page
- Fritsche A, Stumvoll M, Grüb M, Sieslack S, Renn W, Schmülling R-M, et al. Effect of hypoglycemia on β-adrenergic sensitivity in normal and type 1 diabetic subjects. Diabetes Care 1998;21: 1505–1510. · DOI · Paper page
- Segel SA, Paramore DS, Cryer PE. Defective glucose counterregulation in type 2 diabetes. Diabetes 2000;49: A131 (abstract). · DOI
- Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, et al. The dawn phenomenon in type 1 (insulin dependent) diabetes mellitus: magnitude, frequency, variability, and dependence on glucose counterregulation and insulin sensitivity. Diabetes 1991;34: 21–28.
- Jones TW, Porter P, Sherwin RS, Davis EA, O’Leary P, Frazer F, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998;338: 1657–1662. · DOI · Paper page
- Heller SR, Amiel SA, Mansell P, the U.K. Lispro Study Group. Effect of the fast acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. Diabetes Care 1999;22: 1607–1611. · DOI · Paper page
- Saleh TY, Cryer PE. Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM. Diabetes Care 1997;20: 1231–1236. · DOI · Paper page
- Ververs MTC, Rouwé C, Smit GPA. Complex carbohydrates in the prevention of nocturnal hypoglycaemia in diabetic children. Eur J Clin Nutr 1993;47: 268–273.
- Kaufman FR, Devgan S. Use of uncooked cornstarch to avert nocturnal hypoglycemia in children and adolescents with type 1 diabetes. J Diabetes Complications 1996;10: 84–87. · DOI
- Bolli GB. How to ameliorate the problem of hypoglycemia in intensive as well as nonintensive treatment of type 1 diabetes. Diabetes Care 1999;22(Suppl 2): B43-B52.
Cited by
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
“Given the limited accuracy of the monitoring devices, it approximates the lower limit of the normal postabsorptive plasma glucose concentration (15), the glycemic thresholds for activation of glucose counterregulatory systems in nondiabetic individuals (15), and the upper limit of plasma glucose level reported to redu…”
BackgroundSelf-citationCryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citationCryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
Self-citationα-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Gromada, J., Franklin, I., & Wollheim, C. B. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0007 · Cited by 581
Diverse causes of hypoglycemia-associated autonomic failure in diabetes.
Cryer, P. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031354 · Cited by 411
Self-citation
Metadata
- Authors
- Cryer, P. E.
- Venue
- Type 1 Diabetes
- Publisher
- Humana Press
- Published
- 2003
- Pages
- 145-161
- OpenAlex
- W1502400318
- Cited by
- 42
- References
- 62
- FWCI
- 19.30
- Type
- book chapter
- Language
- en
- Open access
- hybrid
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention and Correction of Hypoglycemia: Relevance to Type 1 Diabetes. https://app.cochat.ai/papers/10.1007/978-1-59259-310-1_7
- The paper
- Cryer, P. E. (2003). Prevention and Correction of Hypoglycemia: Relevance to Type 1 Diabetes. Type 1 Diabetes. https://doi.org/10.1007/978-1-59259-310-1_7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.